Oxular
Dmitrij Hristodorov is a Principal at Forbion. Prior to this, he was Senior Director of Global Business Development & Licensing at Bayer Pharma, where he was mainly responsible for ophthalmology, cardiology, nephrology, and pulmonology. His spectrum of activities included scouting, evaluation, negotiation, and transaction for in- and out-licensing. Previously, Dmitrij spent two years in R&D as Head of Pharmacology Lab in Ophthalmology. His activities included target discovery and preclinical development. Dmitrij received his PhD in Immunology (summa cum laude) from the University of Aachen/Fraunhofer IME, Germany, in 2013.
This person is not in the org chart
This person is not in any offices
Oxular
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.